Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.

/by

Authors: Shayna Conner, Victoria Bedell, Kim Lipsey, George Macones, Alison Cahill, Methodius Tuuli
Obstetrics & Gynecology, October 2016
—
OBJECTIVE: To estimate whether marijuana use in pregnancy increases risks for adverse neonatal outcomes and clarify if any increased risk is attributable to marijuana use itself or to confounding factors such as tobacco use. DATA SOURCES: Two authors performed a search of the…

Read more

Marijuana use and its effects in pregnancy.

/by

Authors: Kristin C. Chabarria, Diana A. Racusin, Kathleen M. Antony, Maike Kahr, et al
American Journal of Obstetrics and Gynecology, October 2016
—
BACKGROUND: It is generally assumed that marijuana is one of the more widely used controlled substances during pregnancy. However, there remains a general paucity of population-based data regarding its use and subsequent perinatal morbidity. We hypothesized that direct patient…

Read more

Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.

/by

Authors: Evan J. Hess, Kirsten A. Moody, Alexandra L. Geffrey, Sarah F. Pollack, et al
Epilepsia, October 2016
—
OBJECTIVE: Tuberous sclerosis complex (TSC) is an autosomal-dominant genetic disorder with highly variable expression. The most common neurologic manifestation of TSC is epilepsy, which affects approximately 85% of patients, 63% of whom develop treatment-resistant epilepsy. He…

Read more